Free Trial

Greater Cannabis (GCAN) Competitors

Greater Cannabis logo
$0.0008 +0.00 (+33.33%)
As of 03:57 PM Eastern

GCAN vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Greater Cannabis stock or one of its competitors? The main competitors of Greater Cannabis include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Greater Cannabis vs.

180 Life Sciences (NASDAQ:ATNFW) and Greater Cannabis (NASDAQ:GCAN) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, community ranking, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.

Greater Cannabis received 10 more outperform votes than 180 Life Sciences when rated by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Greater CannabisOutperform Votes
10
76.92%
Underperform Votes
3
23.08%

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Greater Cannabis'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Greater Cannabis Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Greater Cannabis N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Greater CannabisN/AN/AN/AN/AN/A

Summary

Greater Cannabis beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Greater Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for GCAN and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GCAN vs. The Competition

MetricGreater CannabisDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.16B$5.39B$9.13B
Dividend YieldN/A3.04%5.37%4.00%
P/E RatioN/A129.7388.8317.53
Price / SalesN/A2,916.701,284.8380.47
Price / CashN/A10.2536.6032.90
Price / BookN/A3.264.964.69
Net IncomeN/A$152.21M$117.89M$224.57M
7 Day PerformanceN/A0.23%2.74%3.33%
1 Month PerformanceN/A3.14%3.63%5.33%
1 Year PerformanceN/A103.17%27.26%22.97%

Greater Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GCAN
Greater Cannabis
N/A$0.00
+33.3%
N/A-14.3%$0.00N/A0.001Gap Up
ATNFW
180 Life Sciences
N/A$0.01
+3.0%
N/A+73.1%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
-7.3%
N/A+3.8%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.19
+11.8%
N/AN/A$0.00$40,633.000.0040Positive News
Gap Down
ALVOW
Alvotech
N/A$3.25
-1.5%
N/A-4.2%$0.00$391.87M0.004News Coverage
Positive News
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.06
-23.5%
N/AN/A$0.00N/A0.004Gap Up
BFRIW
Biofrontera
N/A$0.09
+1.4%
N/AN/A$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.41
-16.3%
N/AN/A$0.00$193.06M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.17
+3.1%
N/A-92.7%$0.00N/A0.008Short Interest ↑
Positive News
Gap Down
CELUW
Celularity
N/A$0.03
-1.8%
N/AN/A$0.00$48.20M0.00220Positive News

Related Companies and Tools


This page (NASDAQ:GCAN) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners